Morning All!
Versarien ( Versarien (LON:VRS) ) – 44.25p – £65.3m – PER 147.9
Interim Results For The 6 Months To End September 2017 – Revenues up by 167% to £4.38m (H1 2016: £1.64m), Loss Before Tax almost halved to £0.77m (H1 2016: £1.47m), Cash of £0.35m (£1.51m last time) and lots of bullish talk.
A guy down the pub told me about this (well, actually it was a very good long term friend (who is a software test manager) but you get the idea) when it was less than 20p a month or so ago - He said it was going to fly! I said thanks for the tip but I rarely invest in non-profit making companies with barely any Cash left. I may be wrong here, it looks interesting (but so did Applied Graphene Materials (LON:AGM) at 10x it’s current price) – I just prefer to be in less risky places for now.
Eve Sleep ( eve Sleep (LON:EVE) ) – 89p – £123.4m – PER n/a
Trading Update – Headlines with “Strong sales, acceleration of investment, on track for UK profitability in Q4 2018” – Group on track to make a profit in 2019. Marketing costs reducing significantly, seemingly targeting 35% from 64% in H1 2017.
Can’t see the fascination here – It’s a mattress, something we replace every 10 years or so, perhaps. I may be wrong and soon everyone will be using an Eve Sleep mattress. On the other hand the company may continue spending a fortune on advertising and end up dead in the water. It’s just not for me, I sleep well enough at night as it is, don’t need to potentially disrupt this (with the mattress or the holding)!
Redcentric ( Redcentric (LON:RCN) ) – 87.5p – £130.3m – PER 16
Interim Results For The 6 Months To End September 2017 – Headline is “Solid first six months with strong operating cash flows and a reduction in net debt”. Solid here means Revenue and Profits are flat and the Net Debt has been reduced a whopping 2.6%. The CEO comments “The issues surrounding the accounting misstatements have been addressed and so…
